{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT02747303",
            "orgStudyIdInfo": {
                "id": "IRB15-1476"
            },
            "organization": {
                "fullName": "University of Chicago",
                "class": "OTHER"
            },
            "briefTitle": "Frameless Stereotactic Radiosurgery for Intact Brain Metastases",
            "officialTitle": "The Clinical Relevance of Margins in Frameless Stereotactic Radiosurgery for Intact Brain Metastases: a Randomized Trial of 0 vs 2 mm Margins",
            "therapeuticArea": [
                "Other"
            ],
            "study": "frameless-stereotactic-radiosurgery-for-intact-brain-metastases"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-04",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2016-06-10",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-05-10",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-05-10",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2016-04-19",
            "studyFirstSubmitQcDate": "2016-04-19",
            "studyFirstPostDateStruct": {
                "date": "2016-04-21",
                "type": "ESTIMATED"
            },
            "lastUpdateSubmitDate": "2023-04-26",
            "lastUpdatePostDateStruct": {
                "date": "2023-04-28",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "University of Chicago",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false
        },
        "descriptionModule": {
            "briefSummary": "This is a randomized study to determine if not treating planning target volume (PTV) margins during radiation therapy worsens progression free survival rates in patients with brain metastases."
        },
        "conditionsModule": {
            "conditions": [
                "Brain Metastases"
            ],
            "keywords": [
                "brain metastases",
                "Stereotactic Radiosurgery"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 166,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Stereotactic Radiosurgery to 2 mm GTV to PTV margins",
                    "type": "ACTIVE_COMPARATOR",
                    "interventionNames": [
                        "Procedure: Stereotactic Radiosurgery"
                    ]
                },
                {
                    "label": "Stereotactic Radiosurgery to 0 mm GTV to PTV margins",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Procedure: Stereotactic Radiosurgery"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "PROCEDURE",
                    "name": "Stereotactic Radiosurgery",
                    "description": "The SRS dose will depend on the maximum diameter of the gross tumor volume (GTV)",
                    "armGroupLabels": [
                        "Stereotactic Radiosurgery to 0 mm GTV to PTV margins",
                        "Stereotactic Radiosurgery to 2 mm GTV to PTV margins"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Progression free survival (PFS) rates estimated by the Kaplan-Meier method at 6 months",
                    "timeFrame": "6 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Progression free survival (PFS) rates estimated by the Kaplan-Meier method",
                    "timeFrame": "2 years"
                },
                {
                    "measure": "Overall survival rates",
                    "timeFrame": "6 years"
                },
                {
                    "measure": "Rates of radiation necrosis",
                    "timeFrame": "2 years"
                },
                {
                    "measure": "Rates of pseudoprogression",
                    "timeFrame": "2 years"
                },
                {
                    "measure": "Local failure rates",
                    "timeFrame": "2 years"
                },
                {
                    "measure": "Rate of acute central nervous system (CNS) Common Terminology Criteria for Adverse Events (CTCAE) v4.0 grade 2 and higher toxicities",
                    "timeFrame": "90 days"
                },
                {
                    "measure": "Rate of late central nervous system (CNS) Common Terminology Criteria for Adverse Events (CTCAE) v4.0 grade 2 and higher toxicities",
                    "timeFrame": "6 years"
                },
                {
                    "measure": "Rates of distant intracranial failure",
                    "timeFrame": "2 years"
                },
                {
                    "measure": "Rates of salvage therapy",
                    "timeFrame": "2 years"
                },
                {
                    "measure": "Association between dose and risk of radionecrosis or pseudoprogression",
                    "timeFrame": "2 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Adult patients (\u2265 18 years old) with an ECOG Performance Status 0-2 and a life expectancy of 3 months or more.\n* Histologically confirmed systemic malignancy with gadolinium contrast-enhanced MRI scan demonstrating 1-5 intraparenchymal brain metastases.\n* Well-circumscribed, measureable intraparenchymal brain lesion(s) with maximum tumor diameter \u22643.0 cm. If multiple lesions are present, the other(s) must not exceed 3.0 cm in maximum diameter. At least one lesion must be \u22651.0 cm in maximum diameter and \u22650.5 cm in a perpendicular diameter to be considered measurable disease.\n* Negative urine or serum pregnancy test done \u2264 14 days prior to CT simulation, for women of child-bearing potential only.\n* Ability to understand and willingness to sign a written informed consent document.\n\nExclusion Criteria:\n\n* Diagnosis of germ cell tumor, small cell carcinoma or hematologic malignancy.\n* Metastases in the brain stem, midbrain, pons, medulla, or within 7 mm of the optic apparatus (optic nerves, chiasm and optic tracts).\n* Diagnosis of leptomeningeal disease.\n* Prior cranial radiotherapy within 90 days of trial enrollment or prior SRS at any time to any lesion to be treated on protocol\n* Chemotherapy (including oral agents and targeted agents) or immunotherapy given within 14 days of SRS. Hormonal therapy is permitted. For Her2+ breast cancer patients, anti-Her2 therapy cannot be given within 14 days of SRS. Patients who are scheduled to receive trastuzumab emtansine after SRS cannot be enrolled.\n* Contraindications to gadolinium contrast-enhanced MRI (eg, non-compatible pacemaker, eGFR\\<30, gadolinium allergy).",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Robyn Hseu",
                    "role": "CONTACT",
                    "phone": "773-834-3198",
                    "email": "rhseu@radonc.uchicago.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Steven J. Chmura, M.D., Ph.D.",
                    "affiliation": "University of Chicago",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Chicago",
                    "status": "RECRUITING",
                    "city": "Chicago",
                    "state": "Illinois",
                    "zip": "60637",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Robyn Hseu",
                            "role": "CONTACT",
                            "email": "rhseu@radonc.uchicago.edu"
                        },
                        {
                            "name": "Steven J. Chmura, M.D., Ph.D.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.85003,
                        "lon": -87.65005
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009362",
                    "term": "Neoplasm Metastasis"
                },
                {
                    "id": "D000001932",
                    "term": "Brain Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009385",
                    "term": "Neoplastic Processes"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000016543",
                    "term": "Central Nervous System Neoplasms"
                },
                {
                    "id": "D000009423",
                    "term": "Nervous System Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000001927",
                    "term": "Brain Diseases"
                },
                {
                    "id": "D000002493",
                    "term": "Central Nervous System Diseases"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M12307",
                    "name": "Neoplasm Metastasis",
                    "asFound": "Metastases",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5209",
                    "name": "Brain Neoplasms",
                    "asFound": "Brain Metastases",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12330",
                    "name": "Neoplastic Processes",
                    "relevance": "LOW"
                },
                {
                    "id": "M18937",
                    "name": "Central Nervous System Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M12367",
                    "name": "Nervous System Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M5204",
                    "name": "Brain Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5742",
                    "name": "Central Nervous System Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                }
            ]
        }
    },
    "hasResults": false
}